A feminist to the core, Lisa founded SeedFund to empower women to build the wealth they deserve. Driven by endless curiosity and killer instincts, she exceled as an operational leader and head of growth/M&A for a top five global marketing company. She also led strategic planning, financial communication and marketing for a Fortune 200 company. As a founder herself, Lisa understands how insights from corporate strategy and marketing can give start-ups an advantage.

MS, Integrated Marketing – Northwestern University
Board Member, Yellowstone Forever

A. J. believes deeply in the economic opportunity of nature-based markets and the growth potential of women-led companies. His CFO career has spanned multiple complex industries, from public Fortune 200 companies to start-ups. During his 30 years in finance, he has tackled many complex issues—from raising capital and strategic planning, to M&A and global expansion. A. J.’s unique combination of experience brings a keen eye to the SeedFund portfolio and a wealth of experience to advise start-ups in raising capital and strategic planning.

MBA, Finance and Accounting – DePaul University
Board Member, Alliant Power

Kaia Roman has been promoting people, projects, and products working toward a better world for more than two decades. She is the co-founder of telemedicine ketamine treatment company KetaMD, the former Vice President of Strategy & Communications at a psychedelic bioscience research company, and the host of the Psyched podcast by the Women In Psychedelics Network, as well as an accomplished documentary film producer and bestselling author.

Inspired by her personal healing experiences with psychedelic medicine, Kaia is currently working with and investing in cutting-edge companies and thought leaders in the emerging psychedelic industry. Merging 20 years of brand experience work in Silicon Valley with her neuroscience and mindfulness research and training, Kaia is a passionate advocate for the profound healing capabilities of psychedelic compounds.

Dan serves as Head of Field Building for Psychedelic Science Funders Collaborative and as a board member and chair of the impact advisory committee for Lykos Therapeutics. He brings extensive expertise from his tenure as Managing Director and Senior Partner at Boston Consulting Group (BCG).

With over 20 years at BCG, Dan specialized in corporate strategy, pipeline development, and the commercialization of innovation in the healthcare sector, focusing on biopharmaceutical and medical technology companies. Holding a Ph.D. in mathematics from Princeton University and a B.A. from Harvard, Dan's profound knowledge and experience will be invaluable as we support women-led ventures navigating critical growth stages.